About Us

“Presently, we stand at a significant inflection point. Synthetic Biology is to 2022 what the
‘.com’ era was to the 90s.”

Veronica Wu, Founder of First Bight Ventures

_____

Our Team

Veronica wu

Veronica wu

Founder

Carlos Estrada

Carlos Estrada

Program Manager

Mason Darabi, CPA

Mason Darabi, CPA

Venture Partner

Jonathan M. Mercado, PhD

Jonathan M. Mercado, PhD

Investment Associate

COLLIN McCOLL

COLLIN McCOLL

Investment Analyst

sophia vitas

sophia vitas

Fellow

_____

Our Advisors

Lekan Akinyanmi

Lekan Akinyanmi

Lekoil Limited

Kevin Coker

Kevin Coker

Proxima Clinical Research

Guochun Liao, phd

Guochun Liao, phd

IDbyDNA

Mario Maia

Mario Maia

Novozymes

Davy Wang

Davy Wang

Oracle Cloud

Alan McCollough

Alan McCollough

Circuit City (Ret)

Peter Oleksiak

Peter Oleksiak

DTE Energy

Ethel rubin, phd

Ethel rubin, phd

BioHealthInnovations

_____

Our Partners

BioWell, our foundry, will be set in Houston. Forthcoming plans include a microbial lab, analytic lab, as well as large fermentation and cell separation capabilities to enable start-ups to quickly test/iterate and refine their microbes and manufacturing processes. Our experts and entrepreneurs will create an innovative community, offering mentorship, advisory, and other operational support. BioWell will also connect them with industry partners for commercialization.

The Maker Hub’s mission is that Houston becomes the world leader in advanced manufacturing, to create over a 1,000 new manufacturing companies in the next five years, and to prepare Houston’s 21st century manufacturing workforce to fill thousands of high paying advanced manufacturing jobs.

The Greater Houston Partnership champions Houston’s growth and success by bringing together business and civic-minded leaders to address the region’s unique challenges. Its mission is to make Houston one of the best places to live, work and build a business.

BioMADE’s mission is to enable domestic bioindustrial manufacturing at all scales, develop technologies to enhance U.S. bioindustrial competitiveness, de-risk investment in relevant infrastructure, and expand the biomanufacturing workforce to realize the economic promise of industrial biotechnology.